Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd- P -FdCydOct and dCydPam- P -FdUrd in DU-145 human prostate cancer cells

2000 ◽  
Vol 126 (5) ◽  
pp. 247-256 ◽  
Author(s):  
Rosanna M. C. Cattaneo-Pangrazzi ◽  
Herbert Schott ◽  
Heidi Wunderli-Allenspach ◽  
Barbara Rothen-Rutishauser ◽  
Maja Guenthert ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cell Cycle ◽  
Cancer Cells ◽  
Anticancer Drugs ◽  
Human Prostate Cancer ◽  
Prostate Cancer Cells ◽  
Cycle Arrest ◽  
Induction Of Apoptosis ◽  
New Anticancer Drugs

Induction of apoptosis and cell cycle arrest by ethyl acetate fraction of Phoenix dactylifera L. (Ajwa dates) in prostate cancer cells

2018 ◽  
Vol 218 ◽  
pp. 35-44 ◽  
Author(s):  
Muqtadir Baig Mirza ◽  
Ayman I. Elkady ◽  
Atef M. Al-Attar ◽  
Fareeduddin Quadri Syed ◽  
Furkhan Ahmed Mohammed ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cell Cycle ◽  
Ethyl Acetate ◽  
Cancer Cells ◽  
Ethyl Acetate Fraction ◽  
Phoenix Dactylifera ◽  
Prostate Cancer Cells ◽  
Cycle Arrest ◽  
Phoenix Dactylifera L ◽  
Induction Of Apoptosis

scholarly journals Sanggenol L Induces Apoptosis and Cell Cycle Arrest via Activation of p53 and Suppression of PI3K/Akt/mTOR Signaling in Human Prostate Cancer Cells

Nutrients ◽  
2020 ◽  
Vol 12 (2) ◽  
pp. 488 ◽  
Author(s):  
Yeong-Seon Won ◽  
Kwon-Il Seo
Keyword(s):  
Prostate Cancer ◽  
Cell Cycle ◽  
Cell Cycle Arrest ◽  
Cancer Cells ◽  
Mtor Signaling ◽  
Human Prostate ◽  
Human Prostate Cancer ◽  
Prostate Cancer Cells ◽  
Down Regulation ◽  
Cycle Arrest

Prostate cancer is the most common cancer in Western countries. Recently, Asian countries are being affected by Western habits, which have had an important role in the rapid increase in cancer incidence. Sanggenol L (San L) is a natural flavonoid present in the root barks of Morus alba, which induces anti-cancer activities in ovarian cancer cells. However, the molecular and cellular mechanisms of the effects of sanggenol L on human prostate cancer cells have not been elucidated. In this study, we investigated whether sanggenol L exerts anti-cancer activity in human prostate cancer cells via apoptosis and cell cycle arrest. Sanggenol L induced caspase-dependent apoptosis (up-regulation of PARP and Bax or down-regulation of procaspase-3, -8, -9, Bid, and Bcl-2), induction of caspase-independent apoptosis (up-regulation of AIF and Endo G on cytosol), suppression of cell cycle (down-regulation of CDK1/2, CDK4, CDK6, cyclin D1, cyclin E, cyclin A, and cyclin B1 or up-regulation of p53 and p21), and inhibition of PI3K/Akt/mTOR signaling (down-regulation of PI3K, p-Akt, and p-mTOR) in prostate cancer cells. These results suggest the induction of apoptosis via suppression of PI3K/Akt/mTOR signaling and cell cycle arrest via activation of p53 in response to sanggenol L in prostate cancer cells.

Sign in / Sign up

Export Citation Format

Share Document